DiGeorge syndrome is characterized by cardiovascular, thymus and parathyroi
d defects and craniofacial anomalies, and is usually caused by a heterozygo
us deletion of chromosomal region 22q11.2 (del22q11) (ref. 1). A targeted,
heterozygous deletion, named Df(16)1, encompassing around 1 megabase of the
homologous region in mouse causes cardiovascular abnormalities characteris
tic of the human disease(2). Here we have used a combination of chromosome
engineering and P1 artificial chromosome transgenesis to localize the haplo
insufficient gene in the region, Tbx1. We show that Tbx1, a member of the T
-box transcription factor family, is required for normal development of the
pharyngeal arch arteries in a gene dosage-dependent manner. Deletion of on
e copy of Tbx1 affects the development of the fourth pharyngeal arch arteri
es, whereas homozygous mutation severely disrupts the pharyngeal arch arter
y system. Our data show that haploinsufficiency of Tbx1 is sufficient to ge
nerate at least one important component of the DiGeorge syndrome phenotype
in mice, and demonstrate the suitability of the mouse for the genetic disse
ction of microdeletion syndromes.